Key regions: China, South Korea, Canada, India, France
The Analgesics (Pharmacies) market in Suriname is experiencing significant growth due to several factors. Customer preferences for over-the-counter pain medications, increasing healthcare awareness, and the rising incidence of chronic diseases are driving the demand for analgesics in the country. Customer preferences in Suriname are shifting towards self-medication and seeking immediate relief from pain. This trend is fueled by the convenience of purchasing analgesics from pharmacies without a prescription. Surinamese consumers are increasingly relying on over-the-counter pain medications to manage common ailments such as headaches, muscle aches, and joint pain. The availability of a wide range of analgesic products in pharmacies caters to the diverse needs and preferences of customers. The market is also witnessing growth due to the increasing healthcare awareness among Surinamese consumers. With access to information through the internet and social media, people are becoming more conscious about their health and seeking ways to alleviate pain. This has led to a higher demand for analgesics as individuals are proactively managing their pain and discomfort. The rising incidence of chronic diseases in Suriname is another key driver for the growth of the analgesics market. Chronic conditions such as arthritis, back pain, and migraines are becoming more prevalent in the country. As a result, individuals are seeking long-term pain relief solutions, leading to an increased demand for analgesics. Local special circumstances in Suriname also contribute to the development of the analgesics market. The country has a relatively small population, which allows for targeted marketing and product positioning by pharmaceutical companies. This enables them to cater to the specific needs of Surinamese consumers and develop tailored analgesic products. Underlying macroeconomic factors, such as the growth of the healthcare sector and increasing disposable income, are also driving the growth of the analgesics market in Suriname. The country has been experiencing economic growth in recent years, leading to higher purchasing power among consumers. This allows individuals to afford analgesics and invest in their health and well-being. In conclusion, the Analgesics (Pharmacies) market in Suriname is developing due to customer preferences for over-the-counter pain medications, increasing healthcare awareness, the rising incidence of chronic diseases, local special circumstances, and underlying macroeconomic factors. As Surinamese consumers continue to prioritize self-medication and seek immediate relief from pain, the demand for analgesics is expected to further increase in the coming years.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
